aTyr Pharma, Inc. is a pioneering biotherapeutics company based in San Diego, California, dedicated to the development of innovative immunological medicines. Utilizing its proprietary signaling pathway technology, aTyr focuses on creating therapeutics aimed at treating a variety of inflammatory and neuromuscular diseases. The company is actively advancing its pipeline through comprehensive research, strategic collaborations, and a commitment to addressing significant unmet medical needs. By harnessing the power of immune modulation, aTyr is poised to make impactful contributions to the biopharmaceutical industry and drive long-term value for its stakeholders.